Last week, news began to spread that AstraZeneca, the pharmaceutical giant that has its U.S. headquarters in suburban Wilmington, was putting a large, Phase 3 clinical trial of its COVID-19 […]
© 2024 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.